Thrombotic microangiopathy associated with lenvatinib therapy
Systemic thrombotic microangiopathy (TMA) is a serious condition whose early treatment is essential to reduce morbidity and mortality. TMA with only renal involvement has been associated with tyrosine kinase inhibitors, including lenvatinib, a drug used for certain advanced neoplasms. To date, TMA w...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bioscientifica
2023-04-01
|
| Serie: | Endocrine Oncology |
| Soggetti: | |
| Accesso online: | https://eo.bioscientifica.com/view/journals/eo/3/1/EO-22-0078.xml |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|